Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A study assesses Chinese scientists' knowledge of patents and the relationship between scientists' patent-using behaviors and their organizations' mandates.
The 2009 H1N1 pandemic showed that the egg-based technology used to produce the bulk of flu vaccine is not nimble enough to protect during a pandemic. Charles Schmidt reports on progress in synthetic and recombinant technologies that may provide an answer.
New technology has transformed human genetics. It now provides perhaps the single best opportunity to innovate and improve clinical success rates in drug development.
Too few precompetitive consortia are being formed to mitigate lost opportunities and deliver on other potential mutual gains for public and private stakeholders in drug development.